cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Amneal Pharmaceuticals Inc
19 own
29 watching
Current Price
$7.43
$0.05
(0.68%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,093.8M
52-Week High
52-Week High
7.73500
52-Week Low
52-Week Low
2.99000
Average Volume
Average Volume
0.65M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
84.6746
iconMarket Capitalization1,093.8M
icon52-Week High7.73500
icon52-Week Low2.99000
iconAverage Volume0.65M
iconDividend Yield--
iconP/E Ratio84.6746
What does the Amneal Pharmaceuticals Inc do?
Amneal Pharmaceuticals, Inc., formerly known as Atlas Holdings, Inc. (the "Company"), was formed along with its wholly owned subsidiary, K2 Merger Sub Corporation, a Delaware corporation ("Merger Sub"), on October 4, 2017, for the purpose of facilitating the combination of Impax Laboratories, Inc. (now Impax Laboratories, LLC), a Delaware corporation then listed on the Nasdaq Stock Market ("Impax") and Amneal Pharmaceuticals LLC, a Delaware limited liability company ("Amneal").
Read More
How much money does Amneal Pharmaceuticals Inc make?
News & Events about Amneal Pharmaceuticals Inc.
TipRanks Financial Blog
1 year ago
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amneal Pharmaceuticals (AMRX Research Report), Replimune Group ... Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amneal Pharmaceuticals (AMRX Research Report), Replimune Group...
PR Newswire
1 year ago
Thinking about buying stock in Oncolytics Biotech, Eos Energy Enterprises, Rivian Automotive, Carnival Corp, or Amneal Pharmaceuticals? Thinking about buying stock in Oncolytics Biotech, Eos Energy Enterprises, Rivian Automotive, Carnival Corp, or Amneal Pharmaceuticals? PR Newswire NEW YORK, July...
Business Wire
1 year ago
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (Amneal or the Company) today announced it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Companys New Drug Application (NDA) for IPX203 for the treatment of Parkinsons disease. The letter...
Business Wire
1 year ago
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (Amneal or the Company) today announced the launch of its authorized generic for Xyrem1 (Sodium Oxybate) oral solution CIII in the United States. Sodium Oxybate oral solution, 0.5 g/mL is a central nervous system depressant indicated for the treatment of...
Tickeron - Stocks
1 year ago
This is a signal that AMRX's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Frequently Asked Questions
Frequently Asked Questions
What is Amneal Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Amneal Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Amneal Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Amneal Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Amneal Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Amneal Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Amneal Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Amneal Pharmaceuticals Inc?
plus_minus_icon
What percentage is Amneal Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Amneal Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$7.43
$0.05
(0.68%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Kiniksa Pharmaceuticals Ltd
Kiniksa Pharmaceuticals Ltd
$26.12
$0.21 (0.81 %)
Morphic Holding Inc
Morphic Holding Inc
$56.55
$-0.06 (-0.11 %)
Arcus Biosciences Inc
Arcus Biosciences Inc
$15.81
$0.83 (5.54 %)
Cassava Sciences Inc
Cassava Sciences Inc
$14.91
$2.16 (16.94 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Kiniksa Pharmaceuticals Ltd
Kiniksa Pharmaceuticals Ltd
$26.12
$0.21 (0.81 %)
Morphic Holding Inc
Morphic Holding Inc
$56.55
$-0.06 (-0.11 %)
Arcus Biosciences Inc
Arcus Biosciences Inc
$15.81
$0.83 (5.54 %)
Cassava Sciences Inc
Cassava Sciences Inc
$14.91
$2.16 (16.94 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00